Amara Raja Energy & Mobility – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹3,460 Cr | ▲ 16% | ₹2,974 Cr | ▲ 3% | ₹3,351 Cr |
| EBIDT | ₹377 Cr | ▲ 10% | ₹342 Cr | ▲ 1% | ₹374 Cr |
| Net Profit | ₹322 Cr | ▲ 93% | ₹167 Cr | ▲ 112% | ₹152 Cr |
| EPS | ₹17.61 | ▲ 93% | ₹9.11 | ▲ 112% | ₹8.29 |
Verdict
Amara Raja Energy & Mobility posted a strong Q4 FY26 performance with healthy revenue growth and a sharp jump in profitability. Net profit and EPS more than doubled sequentially and showed robust year-on-year expansion, indicating margin improvement and strong operational efficiency. EBITDA growth remained steady, while overall earnings momentum reflects improving demand and strengthening performance across the battery and energy solutions business.
The Phosphate Company – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹29.9 Cr | ▲ 13% | ₹26.5 Cr | ▼ 58% | ₹71.0 Cr |
| EBIDT | ₹2.41 Cr | ▼ 38% | ₹3.91 Cr | ▼ 69% | ₹7.66 Cr |
| Net Profit | ₹1.99 Cr | ▼ 12% | ₹2.26 Cr | ▼ 53% | ₹4.22 Cr |
| EPS | ₹5.52 | ▼ 12% | ₹6.26 | ▼ 53% | ₹11.70 |
Verdict
The Phosphate Company reported mixed Q4 FY26 results with modest sales growth on a year-on-year basis, but profitability remained under pressure. EBITDA, net profit, and EPS declined both YoY and QoQ, indicating margin compression and weaker operational performance during the quarter. The sharp sequential fall in revenue and earnings suggests slowdown in business momentum despite the company maintaining positive sales growth annually.
Patel Retail – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹334 Cr | ▲ 52% | ₹220 Cr | ▲ 8% | ₹309 Cr |
| EBIDT | ₹17.3 Cr | ▲ 11% | ₹15.6 Cr | ▼ 25% | ₹23.1 Cr |
| Net Profit | ₹9.98 Cr | ▲ 39% | ₹7.18 Cr | ▼ 17% | ₹12.0 Cr |
| EPS | ₹2.99 | ▲ 3% | ₹2.89 | ▼ 17% | ₹3.59 |
Verdict
Patel Retail reported strong Q4 FY26 revenue growth with sales rising sharply on both yearly and quarterly basis, indicating healthy business expansion. However, profitability growth remained relatively muted compared to revenue growth due to pressure on operating margins. Sequential decline in EBITDA, net profit, and EPS suggests higher costs or margin compression during the quarter, though overall YoY earnings performance remained positive.
Pine Labs – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹515 Cr | ▲ 24% | ₹416 Cr | ▼ 6% | ₹548 Cr |
| EBIDT | ₹89.3 Cr | ▲ 75% | ₹51.0 Cr | ▼ 14% | ₹104 Cr |
| Net Profit | ₹67.3 Cr | ▲ 62% | ₹37.7 Cr | ▲ 19% | ₹56.6 Cr |
| EPS | ₹0.59 | ▲ 31% | ₹0.45 | ▲ 20% | ₹0.49 |
Verdict
Pine Labs reported strong Q4 FY26 earnings with robust year-on-year growth across revenue, EBITDA, net profit, and EPS. Despite a sequential decline in sales and EBITDA, profitability improved sharply on a QoQ basis, indicating better cost control and operating efficiency. The sharp EBITDA growth reflects margin expansion, while the elevated PE ratio suggests high market expectations for future growth in the fintech and digital payments business.
Container Corporation of India – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹2,263 Cr | ▼ 1% | ₹2,288 Cr | ▼ 2% | ₹2,308 Cr |
| EBIDT | ₹427 Cr | ▼ 3% | ₹441 Cr | ▼ 17% | ₹514 Cr |
| Net Profit | ₹264 Cr | ▼ 12% | ₹300 Cr | ▼ 21% | ₹335 Cr |
| EPS | ₹3.45 | ▼ 12% | ₹3.94 | ▼ 21% | ₹4.38 |
Verdict
Container Corporation of India reported a weak Q4 FY26 performance with declines across revenue, EBITDA, net profit, and EPS on both YoY and QoQ basis. Margins came under pressure as EBITDA declined sharper sequentially compared to revenue, indicating operational weakness and softer logistics demand. Profitability remained under stress due to lower earnings momentum and cost pressures during the quarter.
Sudarshan Chemical Industries – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹2,790 Cr | ▲ 107% | ₹1,349 Cr | ▲ 33% | ₹2,103 Cr |
| EBIDT | ₹227 Cr | ▲ 79% | ₹127 Cr | ▲ 499% | ₹37.9 Cr |
| Net Profit | ₹82.5 Cr | ▲ 203% | ₹0.31 Cr | ▲ Turnaround | Loss of ₹116 Cr |
| EPS | ₹10.01 | ▲ 2025% | ₹-0.52 | ▲ Turnaround | ₹-14.67 |
Verdict
Sudarshan Chemical delivered a sharp recovery in Q4 FY26 with strong double-digit growth in revenue and profitability. EBITDA margins improved significantly on a sequential basis, while the company reported a strong turnaround from the previous quarter’s loss to a healthy profit. The exceptional YoY growth reflects both operational improvement and a low base effect, indicating improving business momentum and better cost efficiency.
Royal Orchid Hotels – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹113 Cr | ▲ 30% | ₹86.7 Cr | Flat | ₹113 Cr |
| EBIDT | ₹25.6 Cr | ▲ 28% | ₹19.9 Cr | ▼ 14% | ₹29.9 Cr |
| Net Profit | ₹8.21 Cr | ▼ 47% | ₹13.2 Cr | ▼ 15% | ₹9.62 Cr |
| EPS | ₹2.90 | ▼ 39% | ₹4.79 | ▼ 12% | ₹3.29 |
Verdict
Royal Orchid Hotels reported strong revenue growth in Q4 FY26, supported by healthy hospitality demand and operational expansion. However, despite higher sales and EBITDA growth on a yearly basis, net profit and EPS declined sharply due to margin pressure and likely higher costs or exceptional expenses. Sequentially, profitability also weakened, indicating softer earnings momentum even as topline performance remained stable.
Suprajit Engineering – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹1,042 Cr | ▲ 19% | ₹877 Cr | ▲ 6% | ₹979 Cr |
| EBIDT | ₹120 Cr | ▲ 38% | ₹87.0 Cr | ▲ 26% | ₹94.9 Cr |
| Net Profit | ₹71.1 Cr | ▲ 161% | ₹27.2 Cr | ▲ 469% | ₹12.5 Cr |
| EPS | ₹5.18 | ▲ 160% | ₹1.99 | ▲ 469% | ₹0.91 |
Verdict
Suprajit Engineering reported a strong Q4 FY26 performance with robust growth across revenue and profitability metrics. EBITDA growth significantly outpaced sales growth, indicating margin expansion and operational efficiency improvements. Net profit and EPS surged sharply both YoY and QoQ, supported by a low sequential base and improved business performance across segments. The results reflect strong earnings momentum and healthy execution during the quarter.
Rail Vikas Nigam Limited – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹6,696 Cr | ▲ 4% | ₹6,427 Cr | ▲ 43% | ₹4,684 Cr |
| EBIDT | ₹269 Cr | ▼ 38% | ₹433 Cr | ▲ 22% | ₹221 Cr |
| Net Profit | ₹182 Cr | ▼ 59% | ₹455 Cr | ▼ 44% | ₹324 Cr |
| EPS | ₹0.90 | ▼ 59% | ₹2.18 | ▼ 42% | ₹1.55 |
Verdict
Rail Vikas Nigam reported muted Q4 FY26 results with marginal revenue growth but sharp pressure on profitability. EBITDA, net profit, and EPS declined significantly on a year-on-year basis, indicating margin compression and higher operational costs. Sequentially, revenue and EBITDA improved strongly, but profit performance remained weak, reflecting continued pressure on earnings despite better execution momentum.
Insolation Energy – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹794 Cr | ▲ 100% | ₹397 Cr | ▲ 38% | ₹575 Cr |
| EBIDT | ₹111 Cr | ▲ 93% | ₹57.4 Cr | ▲ 48% | ₹74.8 Cr |
| Net Profit | ₹69.8 Cr | ▲ 65% | ₹42.4 Cr | ▲ 38% | ₹50.7 Cr |
| EPS | ₹3.17 | ▲ 65% | ₹1.92 | ▲ 38% | ₹2.30 |
Verdict
Insolation Energy posted a very strong Q4 FY26 performance with revenue doubling year-on-year and robust growth across EBITDA, net profit, and EPS. Sequential growth also remained impressive, reflecting strong execution, rising demand, and improving scale benefits in the solar and renewable energy business. Despite rapid earnings growth, the company continues to trade at a relatively moderate valuation, indicating improving investor confidence backed by strong operational momentum.
Jindal Worldwide – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹640 Cr | ▲ 6% | ₹606 Cr | ▲ 20% | ₹532 Cr |
| EBIDT | ₹41.2 Cr | ▼ 16% | ₹49.0 Cr | ▲ 86% | ₹22.2 Cr |
| Net Profit | ₹26.1 Cr | ▲ 19% | ₹22.0 Cr | ▲ 83% | ₹14.3 Cr |
| EPS | ₹0.26 | ▲ 18% | ₹0.22 | ▲ 86% | ₹0.14 |
Verdict
Jindal Worldwide reported moderate revenue growth in Q4 FY26 with strong sequential improvement across profitability metrics. EBITDA declined on a year-on-year basis, indicating margin pressure, but sharp QoQ recovery in EBITDA, net profit, and EPS suggests operational improvement during the quarter. The company maintained healthy profit growth despite higher cost pressures, reflecting stable demand and improving business momentum.
Campus Activewear – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹456 Cr | ▲ 12% | ₹406 Cr | ▼ 23% | ₹589 Cr |
| EBIDT | ₹82.5 Cr | ▲ 15% | ₹71.4 Cr | ▼ 25% | ₹110 Cr |
| Net Profit | ₹44.1 Cr | ▲ 26% | ₹35.0 Cr | ▼ 31% | ₹63.7 Cr |
| EPS | ₹1.44 | ▲ 25% | ₹1.15 | ▼ 31% | ₹2.08 |
Verdict
Campus Activewear reported steady Q4 FY26 growth with double-digit improvement in sales and EBITDA, while net profit growth outpaced revenue growth, reflecting margin improvement and operational efficiency. However, on a sequential basis, revenue and profitability declined sharply from the strong December quarter, indicating seasonality impact and softer near-term momentum. Despite QoQ weakness, the company continues to maintain healthy YoY growth in the sports and athleisure footwear segment.
NBCC (India) – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹4,560 Cr | ▼ 2% | ₹4,644 Cr | ▲ 51% | ₹3,022 Cr |
| EBIDT | ₹287 Cr | ▼ 1% | ₹291 Cr | ▲ 152% | ₹114 Cr |
| Net Profit | ₹254 Cr | ▲ 39% | ₹183 Cr | ▲ 29% | ₹197 Cr |
| EPS | ₹0.89 | ▲ 37% | ₹0.65 | ▲ 25% | ₹0.71 |
Verdict
NBCC reported a mixed Q4 FY26 performance with marginal year-on-year decline in revenue and EBITDA, indicating stable operational execution despite softer topline growth. However, profitability remained strong with sharp growth in net profit and EPS both YoY and QoQ, supported by better margins and execution efficiency. Sequentially, the company showed strong recovery across all major metrics, reflecting improving project activity and healthy business momentum.
Poly Medicure – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹535 Cr | ▲ 21% | ₹441 Cr | ▲ 8% | ₹494 Cr |
| EBIDT | ₹110 Cr | ▼ 8% | ₹119 Cr | ▼ 1% | ₹111 Cr |
| Net Profit | ₹65.0 Cr | ▼ 28% | ₹91.8 Cr | ▼ 8% | ₹70.8 Cr |
| EPS | ₹6.54 | ▼ 28% | ₹9.06 | ▼ 7% | ₹7.00 |
Verdict
Poly Medicure reported healthy revenue growth in Q4 FY26, driven by continued demand across its medical device portfolio. However, profitability remained under pressure with EBITDA, net profit, and EPS declining both YoY and QoQ, indicating margin compression and higher operational costs. Despite strong sales momentum, earnings weakness may keep investors focused on margin recovery in the coming quarters.
Surya Roshni – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹2,163 Cr | ▲ 1% | ₹2,146 Cr | ▲ 12% | ₹1,927 Cr |
| EBIDT | ₹154 Cr | ▼ 24% | ₹202 Cr | ▲ 6% | ₹145 Cr |
| Net Profit | ₹98.3 Cr | ▼ 24% | ₹130 Cr | ▲ 23% | ₹79.7 Cr |
| EPS | ₹4.52 | ▼ 24% | ₹5.98 | ▲ 23% | ₹3.66 |
Verdict
Surya Roshni reported a muted Q4 FY26 performance with flat revenue growth and a sharp decline in profitability on a year-on-year basis, indicating pressure on margins despite stable sales. However, sequential improvement across revenue, EBITDA, net profit, and EPS suggests operational recovery during the quarter. The company’s valuation remains relatively moderate, but margin trends and demand recovery will remain key monitorables ahead.
Suzlon Energy – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹5,493 Cr | ▲ 45% | ₹3,790 Cr | ▲ 30% | ₹4,236 Cr |
| EBIDT | ₹964 Cr | ▲ 39% | ₹693 Cr | ▲ 31% | ₹738 Cr |
| Net Profit | ₹1,114 Cr | ▼ 6% | ₹1,181 Cr | ▲ 150% | ₹445 Cr |
| EPS | ₹0.82 | ▼ 6% | ₹0.87 | ▲ 149% | ₹0.33 |
Verdict
Suzlon Energy reported a strong operational performance in Q4 FY26 with robust growth in revenue and EBITDA both on a year-on-year and quarter-on-quarter basis, driven by higher execution and improved business momentum. However, net profit and EPS declined marginally YoY due to a higher base effect, though sequential profitability improved sharply, reflecting strong recovery in earnings and healthy execution momentum in the renewable energy business.
Saksoft – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹249 Cr | ▲ 4% | ₹240 Cr | ▼ 1% | ₹251 Cr |
| EBIDT | ₹45.2 Cr | ▲ 24% | ₹36.4 Cr | ▼ 0% | ₹45.4 Cr |
| Net Profit | ₹35.9 Cr | ▲ 20% | ₹30.0 Cr | ▲ 24% | ₹29.0 Cr |
| EPS | ₹2.71 | ▲ 19% | ₹2.27 | ▲ 24% | ₹2.19 |
Verdict
Saksoft reported a steady Q4 FY26 performance with modest revenue growth but strong improvement in profitability. EBITDA and net profit outpaced sales growth on a year-on-year basis, indicating margin expansion and operational efficiency. Sequentially, revenue remained largely flat while profit and EPS posted healthy growth, reflecting improved cost management and stable execution in the IT services business.
Shriram Properties – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹641 Cr | ▲ 57% | ₹408 Cr | ▲ 258% | ₹179 Cr |
| EBIDT | ₹69.5 Cr | ▲ 42% | ₹48.8 Cr | Turnaround from Loss | ₹17.0 Cr Loss |
| Net Profit | ₹78.5 Cr | ▲ 64% | ₹47.7 Cr | Turnaround from Loss | ₹6.88 Cr Loss |
| EPS | ₹4.60 | ▲ 64% | ₹2.80 | Turnaround from Loss | ₹0.40 Loss |
Verdict
Shriram Properties reported a sharp turnaround in Q4 FY26 with strong growth across sales, EBITDA, net profit, and EPS. The company moved from losses in the previous quarter to healthy profitability, supported by robust revenue growth and improved operational performance. Strong sequential recovery alongside healthy YoY expansion indicates improving execution momentum in the real estate business.
Zodiac Energy – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹211 Cr | ▲ 23% | ₹171 Cr | ▲ 53% | ₹138 Cr |
| EBIDT | ₹21.8 Cr | ▲ 24% | ₹17.6 Cr | ▲ 59% | ₹13.7 Cr |
| Net Profit | ₹10.6 Cr | ▲ 13% | ₹9.44 Cr | ▲ 109% | ₹5.08 Cr |
| EPS | ₹7.03 | ▲ 12% | ₹6.25 | ▲ 109% | ₹3.36 |
Verdict
Zodiac Energy posted a strong Q4 FY26 performance with robust growth across revenue and operating profit on both year-on-year and quarter-on-quarter basis. The sharp sequential jump in net profit and EPS reflects improved execution and margin expansion. Healthy growth momentum in the renewable energy segment continues to support the company’s earnings trajectory, while the relatively moderate PE compared to sector peers keeps valuations reasonable.
Yatharth Hospital & Trauma Care Services – Q4 FY26 Earnings Highlights
| Metric | Value | YoY Change | YoY Base | QoQ Change | QoQ Base |
|---|---|---|---|---|---|
| Sales | ₹342 Cr | ▲ 47% | ₹232 Cr | ▲ 7% | ₹320 Cr |
| EBIDT | ₹79.9 Cr | ▲ 40% | ₹57.0 Cr | ▲ 8% | ₹74.2 Cr |
| Net Profit | ₹44.7 Cr | ▲ 23% | ₹38.7 Cr | ▲ 4% | ₹43.1 Cr |
| EPS | ₹4.93 | ▲ 23% | ₹4.02 | ▲ 5% | ₹4.71 |
Verdict
Yatharth Hospital delivered a strong Q4 FY26 performance with robust growth across revenue, EBITDA, profit, and EPS. Revenue growth remained significantly strong both YoY and QoQ, supported by rising patient volumes and operational expansion. EBITDA growth stayed healthy, although profit growth was relatively moderate compared to sales growth, indicating some margin normalization. Overall, the company continues to show solid operational momentum and stable earnings growth in the healthcare segment.
